Standard BioTools Q1 2026 Earnings Massive EPS Beat Fails to Lift Shares Amid Revenue Uncertainty OTLK Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Stage Stock Surges on Pipeline Optimism CIMP Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Performance ARLO Q1 2026 Earnings Strong EPS Beat Drives Share Price Higher IOR Q4 2024 Earnings Positive Earnings Amid Limited Market Visibility FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment